Ensign Group, Inc ENSG
6 trading plans running, 29 Form 144 notices for $8.3M
10-Q, 10-K and Form 144What ENSG's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Sep 2, 2025 to Aug 27, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Chad A. Keetch Chief Investment Officer and Executive Vice President |
Adopted 10b5-1 plan | Sep 1, 2026 | 10-Q Oct 27, 2026 | ||
What the company wroteChad A. Keetch, Chief Investment Officer and Executive Vice President, entered into a Rule 10b5-1 trading arrangement on September 1, 2026. Pursuant to the 10b5-1 plan, Mr. Keetch may make gifts of the Company's common stock having an aggregate value of up to $300 thousand between November 30, 2026 and December 31, 2026. | |||||
| Dr. Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | Aug 27, 2026 | 10-Q Oct 27, 2026 | ||
What the company wroteDr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on August 27, 2026. Dr. Blouin's 10b5-1 plan provides for the sale of up to 450 shares of the Company's common stock between November 30, 2026 and August 27, 2027. | |||||
| Barry M. Smith a member of our Board of Directors |
Ended 10b5-1 plan | Jun 10, 2026 | 10-Q Jul 27, 2026 | ||
What the company wroteOn June 10, 2026, Barry M. Smith, a member of our Board of Directors, terminated his previously disclosed Rule 10b5-1 trading arrangement, adopted on July 29, 2025, that provided for recurring monthly sale of up to 700 shares, for an aggregate of up to 8,400 shares of the Company's common stock between January 2, 2026 and December 31, 2026. | |||||
| Daren J. Shaw a member of our Board of Directors |
Ended 10b5-1 plan | May 13, 2026 | 10-Q Jul 27, 2026 | ||
What the company wroteOn May 13, 2026, Daren J. Shaw, a member of our Board of Directors, terminated his previously disclosed Rule 10b5-1 trading arrangement, adopted on May 7, 2025, that provided for the potential sale of up to 4,000 shares of the Company's common stock between August 15, 2025 and May 29, 2026. | |||||
| Marivic Uychiat a member of our Board of Directors |
Adopted 10b5-1 plan | May 6, 2026 | 10-Q Jul 27, 2026 | ||
What the company wroteMarivic Uychiat, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on May 6, 2026. Ms. Uychiat's 10b5-1 Plan provides for the potential exercise of vested stock options and the sale of up to 559 shares of the Company's common stock between August 5, 2026 and May 4, 2027. | |||||
| Dr. Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | Mar 12, 2026 | 10-Q Apr 30, 2026 | ||
What the company wroteDr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on March 12, 2026. Dr. Blouin's 10b5-1 Plan provides for the potential sale of up to 375 shares of the Company's common stock between June 12, 2026 and February 26, 2027. | |||||
| Swati B. Abbott a member of our Board of Directors |
Adopted 10b5-1 plan | Mar 2, 2026 | 10-Q Apr 30, 2026 | ||
What the company wroteSwati B. Abbott, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on March 2, 2026. Ms. Abbott's 10b5-1 Plan provides for the potential sale of up to 1,100 shares of the Company's common stock between June 1, 2026 and March 1, 2027. | |||||
| Spencer Burton President and Chief Operations Officer |
Adopted 10b5-1 plan | Feb 9, 2026 | 10-Q Apr 30, 2026 | ||
What the company wroteSpencer Burton, President and Chief Operations Officer, entered into a Rule 10b5-1 trading arrangement on February 9, 2026. Mr. Burton's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 4,719 shares of the Company's common stock between May 11, 2026 and October 30, 2026. Pursuant to the 10b5-1 Plan, Mr. Burton may also make a gift of up to 2,500 shares of the Company's common stock between May 11, 2026 and October 30, 2026. | |||||
| Dr. Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | Nov 7, 2025 | 10-K Feb 4, 2026 | ||
What the company wroteDr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on November 7, 2025. Dr. Blouin's 10b5-1 Plan provides for the potential sale of up to 375 shares of the Company's common stock between February 9, 2026 and November 5, 2026. | |||||
| Mark V. Parkinson a member of our Board of Directors |
Adopted 10b5-1 plan | Nov 6, 2025 | 10-K Feb 4, 2026 | ||
What the company wroteMark V. Parkinson, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on November 6, 2025. Mr. Parkinson's 10b5-1 Plan provides for the potential sale of up to 400 shares of the Company's common stock between February 9, 2026 and October 15, 2026. | |||||
| Suzanne D. Snapper Chief Financial Officer, Executive Vice President, and Director |
Adopted 10b5-1 plan | Sep 12, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteSuzanne D. Snapper, Chief Financial Officer, Executive Vice President, and Director, entered into a Rule 10b5-1 trading arrangement on September 12, 2025. Ms. Snapper's 10b5-1 plan provides for the potential exercise of vested stock options and the associated sale of up to 16,516 shares of the Company's common stock between January 2, 2026 and May 21, 2027. | |||||
| Beverly B. Wittekind Executive Vice President and General Counsel |
Adopted 10b5-1 plan | Sep 2, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteBeverly B. Wittekind, Executive Vice President and General Counsel, entered into a Rule 10b5-1 trading arrangement on September 2, 2025. Ms. Wittekind's 10b5-1 plan provides for the potential sale of up to 5,900 shares of the Company's common stock and also the potential exercise of vested stock options and the associated sale of up to 5,000 shares of the Company's common stock between December 12, 2025 and July 31, 2026. | |||||
| Christopher R. Christensen Co-founder, Former Executive Chairman, and Former Chairman of the Board |
Adopted 10b5-1 plan | Aug 19, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteChristopher R. Christensen, Co-founder, Former Executive Chairman, and Former Chairman of the Board, entered into a Rule 10b5-1 trading arrangement on August 19, 2025, prior to his retirement from the Board. Mr. Christensen's 10b5-1 plan provides for the potential exercise of vested stock options and the sale of up to 26,800 shares of the Company's common stock between November 21, 2025 and November 28, 2025. | |||||
| Spencer Burton President and Chief Operations Officer |
Adopted 10b5-1 plan | Aug 14, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteSpencer Burton, President and Chief Operations Officer, entered into a Rule 10b5-1 trading arrangement on August 14, 2025. Mr. Burton's 10b5-1 plan provides for the potential exercise of vested stock options and the associated sale of up to 11,798 shares of the Company's common stock between November 17, 2025 and August 31, 2026. Pursuant to the 10b5-1 Plan, Mr. Burton may also make a gift of up to 4,229 shares of the Company's common stock starting on November 17, 2025 and ending on August 31, 2026. | |||||
| Barry R. Port Chief Executive Officer and Chairman of the Board |
Adopted 10b5-1 plan | Aug 12, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteBarry R. Port, Chief Executive Officer and Chairman of the Board, entered into a Rule 10b5-1 trading arrangement on August 12, 2025. Mr. Port's 10b5-1 plan provides for the potential exercise of vested stock options and the associated sale of up to 28,315 shares of the Company's common stock between November 12, 2025 and August 31, 2026. | |||||
| Dr. John O. Agwunobi a member of our Board of Directors |
Adopted 10b5-1 plan | Jul 31, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteDr. John O. Agwunobi, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on July 31, 2025. Dr. Agwunobi's 10b5-1 plan provides for the potential sale of up to 1,421 shares of the Company's common stock between October 30, 2025 and July 20, 2026. | |||||
| Barry M. Smith a member of our Board of Directors |
Adopted 10b5-1 plan | Jul 29, 2025 | 10-Q Nov 3, 2025 | ||
What the company wroteBarry M. Smith, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on July 29, 2025. Mr. Smith's 10b5-1 plan provides for the recurring monthly sale of up to 700 shares, for a total of up to 8,400 shares of the Company's common stock between January 2, 2026 and December 31, 2026. | |||||
| Daren J. Shaw a member of our Board of Directors |
Adopted 10b5-1 plan | May 7, 2025 | 10-Q Jul 24, 2025 | ||
What the company wroteDaren J. Shaw, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on May 7, 2025. Mr. Shaw's 10b5-1 Plan provides for the potential sale of up to 4,000 shares of the Company's common stock between August 15, 2025 and May 29, 2026. | |||||
| Dr. Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | May 2, 2025 | 10-Q Jul 24, 2025 | ||
What the company wroteDr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on May 02, 2025. Dr. Blouin's 10b5-1 Plan provides for the potential sale of up to 425 shares of the Company's common stock between July 31, 2025 and April 30, 2026. | |||||
| Suzanne D. Snapper Chief Financial Officer, Executive Vice President, and Director |
Adopted 10b5-1 plan | Nov 15, 2024 | 10-K Feb 5, 2025 | ||
What the company wroteSuzanne D. Snapper, Chief Financial Officer, Executive Vice President, and Director, entered into a Rule 10b5-1 trading arrangement on November 15, 2024. Ms. Snapper's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,618 shares of the Company's common stock between February 18, 2025 and July 28, 2025. | |||||
| Dr. Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | Nov 12, 2024 | 10-K Feb 5, 2025 | ||
What the company wroteDr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on November 12, 2024. Dr. Blouin's 10b5-1 Plan provides for the sale of up to 450 shares of the Company's common stock between February 11, 2025 and November 11, 2025. | |||||
| Beverly B. Wittekind Executive Vice President and General Counsel |
Adopted 10b5-1 plan | Sep 12, 2024 | 10-Q Oct 24, 2024 | ||
What the company wroteBeverly B. Wittekind, Executive Vice President and General Counsel, entered into a Rule 10b5-1 trading arrangement on September 12, 2024. Ms. Wittekind's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 8,258 shares of the Company's common stock between December 12, 2024 and July 31, 2025. | |||||
| Christopher R. Christensen Co-founder, Executive Chairman and Chairman of the Board |
Adopted 10b5-1 plan | Sep 10, 2024 | 10-Q Oct 24, 2024 | ||
What the company wroteChristopher R. Christensen, Co-founder, Executive Chairman and Chairman of the Board, entered into a Rule 10b5-1 trading arrangement on September 10, 2024. Mr. Christensen's 10b5-1 Plan provides for the potential exercise of vested stock options and the sale of up to 39,086 shares of the Company's common stock between December 18, 2024 and June 18, 2025. | |||||
| Spencer Burton President & Chief Operations Officer |
Adopted 10b5-1 plan | Aug 8, 2024 | 10-Q Oct 24, 2024 | ||
What the company wroteSpencer Burton, President & Chief Operations Officer, entered into a Rule 10b5-1 trading arrangement on August 8, 2024. Mr. Burton's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 5,899 shares of the Company's common stock between November 8, 2024 and August 8, 2025. Pursuant to the 10b5-1 Plan, Mr. Burton may also make a gift of up to 4,229 shares of the Company's common stock starting on January 2, 2025. | |||||
| Barry M. Smith a member of our Board of Directors |
Adopted 10b5-1 plan | Jul 31, 2024 | 10-Q Oct 24, 2024 | ||
What the company wroteBarry M. Smith, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on July 31, 2024. Mr. Smith's 10b5-1 Plan provides for the recurring monthly sale of up to 700 shares, for a total of up to 8,400 shares of the Company's common stock between January 2, 2025 and January 2, 2026. | |||||
| Dr. Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | Jul 31, 2024 | 10-Q Oct 24, 2024 | ||
What the company wroteDr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on July 31, 2024. Dr. Blouin's 10b5-1 Plan provides for the sale of up to 375 shares of the Company's common stock between November 1, 2024 and July 29, 2025. | |||||
| Swati B. Abbott a member of our Board of Directors |
Adopted 10b5-1 plan | Jun 11, 2024 | 10-Q Jul 25, 2024 | ||
What the company wroteSwati B. Abbott, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on June 11, 2024. Ms. Abbott's 10b5-1 Plan provides for the potential sale of up to 1,000 shares of the Company's common stock between September 13, 2024 and June 13, 2025. | |||||
| Barry R. Port Chief Executive Officer and Director |
Adopted 10b5-1 plan | May 6, 2024 | 10-Q Jul 25, 2024 | ||
What the company wroteBarry R. Port, Chief Executive Officer and Director, entered into a Rule 10b5-1 trading arrangement on May 6, 2024. Mr. Port's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 16,517 shares of the Company's common stock between August 5, 2024 and August 31, 2026. | |||||
| Daren J. Shaw a member of our Board of Directors |
Adopted 10b5-1 plan | May 6, 2024 | 10-Q Jul 25, 2024 | ||
What the company wroteDaren J. Shaw, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on May 6, 2024. Mr. Shaw's 10b5-1 Plan provides for the potential sale of up to 8,000 shares of the Company's common stock between August 15, 2024 and May 30, 2025. | |||||
| Chad A. Keetch Chief Investment Officer, Executive Vice President & Secretary |
Adopted 10b5-1 plan | Mar 6, 2024 | 10-Q May 1, 2024 | ||
What the company wroteChad A. Keetch, Chief Investment Officer, Executive Vice President & Secretary, entered into a Rule 10b5-1 trading arrangement on March 6, 2024. Mr. Keetch's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 27,134 shares of the Company's common stock between June 5, 2024 and October 31, 2024. | |||||
| Spencer W. Burton President & Chief Operations Officer |
Adopted 10b5-1 plan | Feb 9, 2024 | 10-Q May 1, 2024 | ||
What the company wroteSpencer W. Burton, President & Chief Operations Officer, entered into a Rule 10b5-1 trading arrangement on February 9, 2024. Mr. Burton's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,618 shares of the Company's common stock between May 10, 2024 and July 30, 2025. Pursuant to the 10b5-1 Plan, Mr. Burton may also make a gift of up to 4,725 shares of the Company's common stock on May 10, 2024. | |||||
| Ann S. Blouin a member of our Board of Directors |
Adopted 10b5-1 plan | Feb 6, 2024 | 10-Q May 1, 2024 | ||
What the company wroteAnn S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on February 6, 2024. Dr. Blouin's 10b5-1 Plan provides for the potential sale of up to 350 shares of the Company's common stock between May 7, 2024 and February 5, 2025. | |||||
| Beverly B. Wittekind Vice President & General Counsel |
Adopted 10b5-1 plan | Dec 8, 2023 | 10-K Feb 1, 2024 | ||
What the company wroteBeverly B. Wittekind, Vice President & General Counsel, entered into a Rule 10b5-1 trading arrangement on December 8, 2023 (the "Rule 10b5-1 Plan"). Ms. Wittekind's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,000 shares of the Company's common stock between March 14, 2024 and October 31, 2024. | |||||
| Christopher R. Christensen Co-founder, Executive Chairman and Chairman of the Board |
Adopted 10b5-1 plan | Nov 2, 2023 | 10-K Feb 1, 2024 | ||
What the company wroteChristopher R. Christensen, Co-founder, Executive Chairman and Chairman of the Board, entered into a Rule 10b5-1 trading arrangement on November 2, 2023 (the "Rule 10b5-1 Plan"). Mr. Christensen's 10b5-1 Plan provides for the potential sale of up to 110,700 shares of the Company's common stock between February 6, 2024 and December 31, 2024. | |||||
| Spencer W. Burton President & Chief Operations Officer |
Adopted 10b5-1 plan | Sep 12, 2023 | 10-Q Oct 25, 2023 | ||
What the company wroteSpencer W. Burton, President & Chief Operations Officer, entered into a Rule 10b5-1 trading arrangement on September 12, 2023 (the "Rule 10b5-1 Plan"). Mr. Burton's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 8,280 shares of the Company's common stock between December 14, 2023 and August 30, 2024. Pursuant to the 10b5-1 Plan, Mr. Burton may also make a gift of up to 2,380 shares of the Company's common stock starting on December 14, 2023. | |||||
| Daren J. Shaw member of our Board of Directors |
Adopted 10b5-1 plan | May 23, 2023 | 10-Q Jul 27, 2023 | ||
| Chad A. Keetch Chief Investment Officer, Executive Vice President & Secretary |
Adopted 10b5-1 plan | May 5, 2023 | 10-Q Jul 27, 2023 | ||
| Ann S. Blouin member of our Board of Directors |
Adopted 10b5-1 plan | May 1, 2023 | 10-Q Jul 27, 2023 | ||
Show the other 30 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 26, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 16, 2026 | Parkinson Mark Vincent Director |
100 | $18K |
| Jul 27, 2026 | Blouin Ann Scott Director |
375 | $69K |
| Jul 20, 2026 | Agwunobi John O Director |
392 | $67K |
| Jul 16, 2026 | Parkinson Mark Vincent Director |
100 | $17K |
| Jun 2, 2026 | SMITH BARRY M Director |
700 | $115K |
| May 4, 2026 | SMITH BARRY M Director |
700 | $128K |
| Apr 20, 2026 | Agwunobi John O Director |
392 | $78K |
| Apr 16, 2026 | Parkinson Mark Vincent Director |
100 | $20K |
| Apr 2, 2026 | SMITH BARRY M Director |
700 | $138K |
| Mar 2, 2026 | SMITH BARRY M Director |
700 | $149K |
| Feb 20, 2026 | Uychiat Pison Marivic Officer, Director |
67 | $14K |
| Feb 19, 2026 | Uychiat Pison Marivic Officer, Director |
83 | $18K |
| Feb 19, 2026 | Wittekind Beverly B. Officer |
500 | $105K |
| Feb 17, 2026 | Shaw Daren Director |
1,000 | $213K |
| Feb 9, 2026 | Blouin Ann Scott Director |
375 | $74K |
| Feb 9, 2026 | Parkinson Mark Vincent Director |
100 | $20K |
| Feb 6, 2026 | Snapper Suzanne D. Officer, Director |
4,573 | $897K |
| Feb 5, 2026 | Snapper Suzanne D. Officer, Director |
8,258 | $1.6M |
| Feb 2, 2026 | SMITH BARRY M Director |
700 | $120K |
| Jan 21, 2026 | Agwunobi John O Director |
146 | $26K |
| Jan 20, 2026 | Agwunobi John O Director |
246 | $44K |
| Jan 2, 2026 | SMITH BARRY M Director |
700 | $122K |
| Dec 19, 2025 | Wittekind Beverly B. Officer |
2,000 | $360K |
| Dec 12, 2025 | Wittekind Beverly B. Officer |
8,400 | $1.5M |
| Dec 1, 2025 | SMITH BARRY M Director |
700 | $129K |
| Nov 20, 2025 | Burton Spencer Officer |
3,690 | $664K |
| Nov 18, 2025 | Burton Spencer Officer |
2,209 | $398K |
| Nov 18, 2025 | Shaw Daren Director |
1,000 | $179K |
| Nov 17, 2025 | Burton Spencer Officer |
5,899 | $1.0M |
Show the other 21 notices
From the Form 144 XML filed with the SEC, since Nov 17, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ENSG/export.csv") into a cell.